Consequently, combination of Olig2 gene transduction and Shh treatment can induce motor neuronal differentiation of human NSCs, and these NSC-derived motor neurons might serve as a source of cell therapy for ALS patients. The gene discussed is SHH; the disease is amyotrophic lateral sclerosis.